TAP Consulting’s Amgen AMGN Stock Holding History

TAP Consulting’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-28	Closed	-$6K	–	152
2021 Q4	$6K	Buy	+28	New	+$5.91K	﹤0.01%	453

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TAP Consulting's AMGN Position: Q1 2022 in Review

TAP Consulting sold out of Amgen (AMGN) in Q1 2022, closing a stake of 28 shares — an estimated $6K sold.

TAP Consulting first reported a position in AMGN in Q4 2021 and held it in 1 quarter. The position peaked at $6K in Q4 2021. 2,338 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

TAP Consulting reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
TAP Consulting sold 28 Amgen shares in Q1 2022, an estimated $6K.
TAP Consulting first reported a position in Amgen in Q4 2021 and held it in 1 quarter.
TAP Consulting's Amgen position peaked at $6K in Q4 2021.
2,338 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on TAP Consulting's 13F filing for Q1 2022, filed 26 Apr 2022.